Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,355 | 434 | 99.4% |
| Education | $44.49 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,499 | 99 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $999.90 | 47 | $0 (2024) |
| Lilly USA, LLC | $955.97 | 82 | $0 (2024) |
| Amgen Inc. | $623.83 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $541.36 | 18 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $439.36 | 26 | $0 (2021) |
| ABBVIE INC. | $374.64 | 22 | $0 (2024) |
| Amarin Pharma Inc. | $273.65 | 21 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $266.10 | 6 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $255.33 | 21 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,176 | 66 | Bayer Healthcare Pharmaceuticals Inc. ($348.67) |
| 2023 | $1,319 | 78 | Lilly USA, LLC ($367.25) |
| 2022 | $664.45 | 40 | Novo Nordisk Inc ($221.27) |
| 2021 | $680.18 | 45 | Novo Nordisk Inc ($187.55) |
| 2020 | $823.60 | 52 | AstraZeneca Pharmaceuticals LP ($267.22) |
| 2019 | $667.41 | 36 | AstraZeneca Pharmaceuticals LP ($209.49) |
| 2018 | $642.09 | 32 | AstraZeneca Pharmaceuticals LP ($196.16) |
| 2017 | $1,428 | 89 | AstraZeneca Pharmaceuticals LP ($285.22) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 3 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Inflammation | ||||||
| 03/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Diabetes | ||||||
| 01/27/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 01/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Diabetes | ||||||
| 01/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 01/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 01/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: Diabetes | ||||||
| 12/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Diabetes | ||||||
| 12/22/2023 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: OSTEOPOROSIS | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gastroenterology | ||||||
| 12/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Inflammation | ||||||
| 12/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 11/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 333 | 578 | $107,374 | $35,906 |
| 2022 | 13 | 605 | 1,046 | $91,750 | $60,429 |
| 2021 | 20 | 770 | 1,332 | $106,970 | $68,599 |
| 2020 | 20 | 1,167 | 2,390 | $151,095 | $82,141 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 62 | 62 | $1,550 | $1,096 | 70.7% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 30 | 30 | $1,500 | $876.90 | 58.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 43 | 82 | $2,460 | $792.94 | 32.2% |
| 96360 | Hydration infusion into a vein 31 minutes to 1 hour | Office | 2020 | 21 | 29 | $2,175 | $653.17 | 30.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 44 | 49 | $2,695 | $575.34 | 21.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 116 | 172 | $1,720 | $505.32 | 29.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 30 | 30 | $900.00 | $486.60 | 54.1% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 11 | 12 | $1,200 | $457.43 | 38.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 55 | 104 | $1,560 | $229.95 | 14.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2020 | 29 | 190 | $3,325 | $74.92 | 2.3% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 15 | 25 | $250.00 | $46.92 | 18.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 26 | 110 | $825.00 | $46.64 | 5.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 13 | 92 | $460.00 | $7.66 | 1.7% |
About Dr. Melecia Fuentes, M.D
Dr. Melecia Fuentes, M.D is a Family Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083713952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melecia Fuentes, M.D has received a total of $7,400 in payments from pharmaceutical and medical device companies, with $1,176 received in 2024. These payments were reported across 438 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,355).
As a Medicare-enrolled provider, Fuentes has provided services to 2,875 Medicare beneficiaries, totaling 5,346 services with total Medicare billing of $247,076. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Weslaco, TX
- Active Since 09/21/2006
- Last Updated 07/03/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083713952
Products in Payments
- FARXIGA (Drug) $890.27
- Ozempic (Drug) $780.89
- MOUNJARO (Drug) $559.71
- Kerendia (Drug) $541.36
- JARDIANCE (Drug) $356.80
- Rybelsus (Drug) $297.10
- Vascepa (Drug) $273.65
- Livalo (Drug) $255.33
- Victoza (Drug) $240.66
- TOUJEO (Drug) $198.59
- TRULICITY (Drug) $174.03
- Prolia (Biological) $168.43
- XARELTO (Drug) $165.42
- Otezla (Drug) $148.96
- Aimovig (Biological) $148.50
- SOLIQUA (Drug) $135.84
- VRAYLAR (Drug) $128.66
- Synthroid (Drug) $125.80
- BYDUREON (Drug) $109.63
- INVOKANA (Drug) $100.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weslaco
Dr. Alejandro Fuentes, M.d, M.D
Family Medicine — Payments: $5,116
Dr. Donna Mery, M.d, M.D
Family Medicine — Payments: $4,323
Dr. Roger Heredia, M.d, M.D
Family Medicine — Payments: $3,405
Larissa Riojas, Do, DO
Family Medicine — Payments: $3,282
Martha Cano, Md, MD
Family Medicine — Payments: $2,563
Pamela Ramirez Stroman, M.d, M.D
Family Medicine — Payments: $2,176